Kautzky-Willer A - Search Results

1

The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome.

Schindler K, Vila G, Hoppichler F, Lechleitner M, Luger A, Anderwald C, Hoefler J, Tomasec G, Kautzky-Willer A, Ludvik B. Schindler K, et al. Obes Facts. 2012;5(2):270-6. doi: 10.1159/000338729. Epub 2012 Apr 21. Obes Facts. 2012. PMID: 22647307 Free article.

2

Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects.

Kautzky-Willer A, Pacini G, Ludvik B, Schernthaner G, Prager R. Kautzky-Willer A, et al. Metabolism. 1992 Dec;41(12):1304-12. doi: 10.1016/0026-0495(92)90100-o. Metabolism. 1992. PMID: 1461136

3

Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study.

Capek M, Schnack C, Ludvik B, Kautzky-Willer A, Banyai M, Prager R. Capek M, et al. Clin Investig. 1994 Dec;72(12):961-6. doi: 10.1007/BF00577736. Clin Investig. 1994. PMID: 7711427 Clinical Trial.

4

Intravenous calcitriol normalizes insulin sensitivity in uremic patients.

Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R. Kautzky-Willer A, et al. Kidney Int. 1995 Jan;47(1):200-6. doi: 10.1038/ki.1995.24. Kidney Int. 1995. PMID: 7731147 Free article.

5

Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.

Ludvik B, Clodi M, Kautzky-Willer A, Schuller M, Graf H, Hartter E, Pacini G, Prager R. Ludvik B, et al. J Clin Invest. 1994 Nov;94(5):2045-50. doi: 10.1172/JCI117558. J Clin Invest. 1994. PMID: 7962550 Free PMC article.

6

Role of islet amyloid polypeptide secretion in insulin-resistant humans.

Kautzky-Willer A, Thomaseth K, Pacini G, Clodi M, Ludvik B, Streli C, Waldhäusl W, Prager R. Kautzky-Willer A, et al. Diabetologia. 1994 Feb;37(2):188-94. doi: 10.1007/s001250050092. Diabetologia. 1994. PMID: 8163054

7

Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans.

Ludvik B, Clodi M, Kautzky-Willer A, Capek M, Hartter E, Pacini G, Prager R. Ludvik B, et al. Diabetologia. 1993 Jan;36(1):84-7. doi: 10.1007/BF00399099. Diabetologia. 1993. PMID: 8436259

8

Elevated hepatic insulin extraction in essential hypertension.

Kautzky-Willer A, Pacini G, Weissel M, Capek M, Ludvik B, Prager R. Kautzky-Willer A, et al. Hypertension. 1993 May;21(5):646-53. doi: 10.1161/01.hyp.21.5.646. Hypertension. 1993. PMID: 8491499

9

Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects.

Kautzky-Willer A, Thomaseth K, Clodi M, Ludvik B, Waldhäusl W, Prager R, Pacini G. Kautzky-Willer A, et al. Metabolism. 1996 Apr;45(4):486-91. doi: 10.1016/s0026-0495(96)90224-3. Metabolism. 1996. PMID: 8609836 Clinical Trial.

10

Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes.

Kautzky-Willer A, Thomaseth K, Ludvik B, Nowotny P, Rabensteiner D, Waldhäusl W, Pacini G, Prager R. Kautzky-Willer A, et al. Diabetes. 1997 Apr;46(4):607-14. doi: 10.2337/diab.46.4.607. Diabetes. 1997. PMID: 9075800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters